Roundup Maker to Pay $10 Billion to Settle Cancer Suits
Part of the discrepancy between the international agency’s conclusions and so many other investigators’ findings
suits
For little work, Grainger sold suits to U.S. for double the cost
WASHINGTON — It pays to be the middleman — especially in a time of crisis.